Published in PLoS One on October 27, 2016
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol (2008) 4.56
Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol (2008) 3.10
Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine samples stored at -20 degrees C. Clin Chem (1992) 2.41
Biological markers of acute kidney injury. J Am Soc Nephrol (2011) 2.36
Recalibration of blood analytes over 25 years in the atherosclerosis risk in communities study: impact of recalibration on chronic kidney disease prevalence and incidence. Clin Chem (2015) 1.66
Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay. Clin Chim Acta (2009) 1.65
The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol (2010) 1.63
Urine stability studies for novel biomarkers of acute kidney injury. Am J Kidney Dis (2013) 1.58
Insights on urinary NGAL obtained in a primary care setting. Clin Chim Acta (2012) 1.53
Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem (2009) 1.50
Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status. Ann Clin Biochem (2014) 1.47
Tubular proteinuria in acute kidney injury: a critical evaluation of current status and future promise. Ann Clin Biochem (2010) 1.36
Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL). Am J Kidney Dis (2013) 1.21
Urinary fatty acid binding protein in renal disease. Clin Chim Acta (2006) 1.12
Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial. Clin Chem (2011) 1.07
Long-term stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain-immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at -20 degrees C. Scand J Urol Nephrol (1997) 1.02
Instability of urinary NGAL during long-term storage. Am J Kidney Dis (2009) 0.99
Long-term Stability of Urinary Biomarkers of Acute Kidney Injury in Children. Am J Kidney Dis (2015) 0.89
Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage. Cancer Causes Control (2014) 0.85
Considerations when measuring urinary albumin: precision, substances that may interfere, and conditions for sample storage. Clin Chem (1991) 0.85
Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia (1993) 0.84
Collection and storage requirements for urinary kidney injury molecule-1 (KIM-1) measurements in humans. Clin Chem Lab Med (2011) 0.83
How and how long to store urine samples before albumin radioimmunoassay: a practical response. Clin Chem (1993) 0.83
Assessing the agreement of biomarker data in the presence of left-censoring. BMC Nephrol (2014) 0.78